Psoriatic arthritis (PsA) is part of a group of closely related clinical phenotypes ('psoriatic
disease') that is defined by shared molecular pathogenesis resulting in excessive …

Psoriasis and psoriatic arthritis (PsA) are common diseases associated with considerable
morbidity and disability. Their pathophysiology comprises a dysfunctional stromal–immune …

Psoriasis is a chronic skin disorder affecting approximately 1% to 3% of the world's
population. A considerable proportion of patients with psoriasis will develop a form of …

Psoriatic arthritis occurs in a subset of psoriasis patients and is therefore commonly
encountered in dermatology practice. Although its exact pathogenesis is unknown, psoriatic …

Psoriatic arthritis (PsA) is characterised by several unique clinical features that differentiate it
from rheumatoid arthritis (RA). Attempts to identify immunopathological mechanisms, some …

Arthritis associated with psoriasis was first described in 1956 by Wright. 1 It was not until
1973, however, that Moll and Wright 2 defined the various clinical phenotypes, including …

Psoriasis is a symmetric autoimmune/inflammatory disease that primarily affects the skin. In
a significant proportion of cases, it is accompanied by arthritis that can affect any joint, the …

Psoriatic arthritis (PsA), a heterogeneous chronic inflammatory immune-mediated disease
characterized by musculoskeletal inflammation (arthritis, enthesitis, spondylitis, and …

Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy associated with psoriasis.
Pathogenesis is incompletely understood and pathophysiological role of synovium is just …

Psoriasis is a common, chronic inflammatory skin disease associated with multi-system
manifestations including arthritis and obesity. Our knowledge of the aetiology of the …